INTRODUCTION
There are two consecutive waves of hematopoiesis in vertebrates, namely primitive hematopoiesis and definitive hematopoiesis. Primitive hematopoiesis refers to the production of primitive erythrocytes during early embryogenesis, whereas definitive hematopoiesis is characterized by the occurrence of hematopoietic stem cells (HSCs) and their subsequent differentiation into all lineages of bloods cells (Orkin and Zon, 2008) . Importantly, recent studies showed that the earliest hematopoietic progenitor cells derive from hemogenic endothelial cells during hematopoietic differentiation of mouse embryonic stem cells (mESCs), without apparent signs of asymmetric cell division (Eilken et al., 2009; Lancrin et al., 2009 ). In vivo time-lapse imaging studies also demonstrated that HSCs emerge directly from aortic hemogenic endothelial cells in the zebrafish and mouse embryos (Bertrand et al., 2010a; Boisset et al., 2010; Kissa and Herbomel, 2010) . This type of cell transition, called endothelial-to-hematopoietic transition (EHT), plays a fundamental role in the generation of hematopoietic stem and progenitor cells, but how it is regulated by the environmental signals still remains elusive. Interestingly, the process of EHT is reminiscent of epithelial to mesenchymal transition (EMT), both of which are characterized by tight-junction dissolution, loss of cell polarity, increased cell mobility, and gain of stem cell-like properties (Thiery et al., 2009) . Whether these two types of cell transition share common regulatory mechanisms also remains to be determined.
G protein-coupled receptors (GPCRs) belong to the largest and most versatile cell-surface receptor superfamily. They receive and transmit a variety of environmental signals into the cell, and actively participate in the regulation of immune responses and higher recognitions (Gainetdinov et al., 2004; Marinissen and Gutkind, 2001) . Recently, prostaglandin E2 receptor signaling was shown to regulate HSC homeostasis through genetically interacting with Wnt pathway (Goessling et al., 2009; North et al., 2007) . Besides, we also identified that b-arrestin1, an important GPCR signaling molecule, is essential for zebrafish primitive hematopoiesis, further suggesting that GPCR signaling plays important roles during vertebrate hematopoiesis (Yue et al., 2009) . Thrombin receptor (F2r), also called protease-activated receptor 1 (PAR1), is a prototypical GPCR activated by thrombin (F2) as well as other proteases. After cleavage of the extreme N-terminal peptide, the exposed tethered ligand of F2r activates itself, and participates in such diverse physiological processes as coagulation, inflammation, and vascular homeostasis (Leger et al., 2006) . Interestingly, nearly half of the F2r knockout mice died in midgestation due to impaired vascular development and severe bleeding, whereas endothelial cell-specific reintroduction of F2r rescued the phenotype (Griffin et al., 2001) . Because vascular development and hematopoietic development closely associate with each other, it is highly possible that F2r signaling also regulates hematopoiesis.
Combining with bioinformatic, pharmacological, and genetic analyses, we identified F2r signaling as a negative regulator of vertebrate hematopoiesis both in vitro and in vivo. More impor- tantly, RhoA/ROCK pathway was identified to function downstream of F2r, revealing an important regulatory mechanism of EHT by extracellular signals.
RESULTS

Correlation between F2r
Expression and Hematopoiesis To identify potential GPCRs regulating vertebrate hematopoiesis, we analyzed two microarray data sets characterizing the gene expression profiles of mESC differentiation (Hailesellasse Sene et al., 2007) . Clustering analysis showed that there are three patterns of differentially expressed GPCRs ( Figure 1A ), in which six receptors were identified as statistically significant in both J1 and R1 mESCs (data not shown). Gene ontology (GO) analysis showed that one of these GPCRs, F2r or PAR1, plays key roles in circulatory system and functions as a positive regulator of blood coagulation and vascular development (GO:0007596). F2r is constitutively upregulated and negatively correlated with hematopoietic transcription factors cmyb and pu.1 (cmyb: Pearson correlation r = À0.60, p = 0.05; pu.1: Pearson correlation r = À0.55, p = 0.08). In addition, the expression pattern of antithrombin, an inhibitor of F2 and coagulation (Olds et al., 1994; Olson and Bjö rk, 1994) , is positively correlated with that of cmyb (Pearson correlation r = 0.66, p = 0.03), suggesting the negative correlation between F2r signaling and hematopoiesis ( Figure 1B) .
Next, we set up a mESC hematopoietic differentiation system (McKinney-Freeman et al., 2008) , and confirmed the expression pattern of F2r using real-time quantitative PCR (qPCR; Figure 1C ). Interestingly, prothrombin (F2), the prototypical activating protease of F2r, is also significantly upregulated during hematopoietic differentiation ( Figure 1D ). To evaluate the physiological relevance of F2r signaling in vivo, we detected the spatiotemporal expression of F2r and F2 during zebrafish embryogenesis. Consistent with the mESC hematopoietic differentiation model, both F2r and F2 were significantly upregulated after 12 hr postfertilization (hpf; Figures 1E and 1F ). In addition, whole-mount in situ hybridization (WISH) analyses revealed that F2r mRNA mainly localized in the vascular endothelium, and closely associated with primitive hematopoietic site (intermediate cell mass, ICM) at 22 hpf and definitive hematopoietic site (aorta-gonadmesonephros, AGM) at 36 hpf ( Figure 1G ). Interestingly, this expression pattern is nearly identical to that of zebrafish F2 as previously reported (Day et al., 2004) , indicating that F2r signaling is functionally active during hematopoietic development.
F2r Negatively Regulates mESC Hematopoietic Differentiation
To elucidate the role of F2r signaling during mESC hematopoietic differentiation, we used both pharmacological and genetic approaches to modulate F2r signal transduction. CD41 is the earliest cell surface hematopoietic marker and indicates the efficiency of hematopoietic differentiation. Application of F2r-specific antagonist SCH79797 significantly increased CD41 + cell percentage (Figures 2A-2C ). This effect was dose dependent and most striking when SCH79797 was added from embryoid body (EB) day 2 to day 6 ( Figure 2D , and see Figure S1A available online). Consistently, qPCR analyses revealed that hematopoietic transcription factors gata1, scl, cmyb, and runx1, as well as b-h1 and b-major hemoglobins, were all upregulated following SCH79797 treatment ( Figure 2E ). In contrast, the marker genes for the three germ layers were not generally affected (Li et al., 2010) (Figure S1B ). We also performed methylcellulose-based colony-forming cell assay (M3434), a functional assay that measures both hematopoietic progenitor types and numbers. F2r antagonism significantly increased primitive erythroid (Ery-P) numbers ( Figure 2F ), as well as definitive erythroid (cfu-E) and granulocyte/monocyte (cfu-G/M/GM) numbers ( Figure 2G ).
To rule out the nonspecific effects of SCH79797 (Di Serio et al., 2007) , we knocked down F2r with two independent siRNAs (Figure S1C) . Consistent with the F2r antagonism results, genetic inhibition of F2r significantly increased CD41 + cell percentage and the expression of hematopoietic markers (Figures 2H and 2I) , without affecting the formation of three germ layers (Figure S1D) . In addition, the Ery-P numbers (Figures 2J and S1E), as well as cfu-E and cfu-G/M/GM numbers, were all increased after F2r knockdown (Figures 2K and S1F), indicating that F2r inhibition promotes mESC hematopoietic differentiation. On the other hand, application of F2r agonist peptide TFLLR-NH 2 did not inhibit hematopoietic differentiation (data not shown), possibly due to the fact that endogenous F2 is dramatically increased during differentiation ( Figure 1D ), which activates F2r at even subnanomolar range (Leger et al., 2006) . However, we did find that overexpressing F2r inhibited CD41 + cell percentage and the expression of hematopoietic marker genes (Figures S1G-S1I). Taken together, these results demonstrated that F2r signaling negatively regulates mESC hematopoietic differentiation.
F2r-RhoA/ROCK Pathway Regulates EHT In Vitro Next, we tried to explore the downstream mechanisms of F2r signaling during hematopoietic differentiation. We first hypothesized that F2r signaling may crosstalk with known hematopoietic pathways. To test this hypothesis, we applied SCH79797 together with the inhibitors of BMP pathway, FGF pathway, Hedgehog pathway, Notch pathway, or NO pathway, and analyzed their corresponding effects on mESC hematopoietic differentiation (Zon, 2008) . Consistent with the fact that BMP pathway is a crucial initiator of mesoderm and hematopoiesis (Sö derberg et al., 2009 ), inhibition of BMP pathway completely blocked hematopoietic differentiation. In contrast, inhibition of other pathways did not significantly abolish the effects of SCH79797, suggesting that pathway crosstalk may not be the main mechanism, and that F2r may directly regulate hematopoietic differentiation through its downstream signaling events ( Figure S2A) .
F2r couples to G 12/13 , Gq, and Gi, and transmits extracellular signals by activating RhoA/ROCK and PKC, or by inhibiting cAMP production (Hung et al., 1992; Lidington et al., 2000; Vouret-Craviari et al., 2002) . To substantiate which pathway mediates F2r signaling, we applied inhibitors of ROCK, Rac1, Gi, or PKC during mESC hematopoietic differentiation, and compared their effects with that of SCH79797. Interestingly, ROCK inhibitors Y-27632 and H1152 significantly increased CD41 + cell percentage, whereas Rac1, Gi, and PKC inhibitors had no such effects ( Figure S2B ). GTPase pull-down assay showed that F2r knockdown by siRNA led to decreased RhoA activity (66% ± 8.6%; p = 0.0165) in day 4 whole EBs, further suggesting that RhoA activity is negatively correlated with hematopoietic potential (data not shown). In an effort to further clarify the role of RhoA/ROCK signaling, we used both flow cytometry and qPCR as readouts and examined the effects of a constitutively active form of RhoA, RhoA-CA (Q63L), alone and in combination with SCH79797 ( Figures 3A and 3B) , and further compared the effects of Y-27632 in the presence and absence of overexpressed F2r ( Figures 3C and 3D ). These data support the idea that F2r and RhoA/ROCK work together to control hematopoietic differentiation. There are two sequential steps during mESC hematopoietic differentiation: (1) the formation of flk1 + hemangioblasts, common progenitors of endothelial and hematopoietic cells, followed by the transition from hemangioblasts to hemogenic endothelial cells, and (2) generation of CD41 + hematopoietic cells via EHT (Eilken et al., 2009; Lancrin et al., 2009 ). To substantiate which step the F2r-RhoA/ROCK pathway regulates, flk1 + hemangioblasts were sorted from day 4 EBs and analyzed by blast colony-forming cell (BL-CFC) assay (Kennedy et al., 1997) . Consistent with previous observations (Eilken et al., 2009; Lancrin et al., 2009) , sorted hemangioblasts first formed tightly adherent hemogenic endothelial cell colonies in BL-CFC medium, which then gradually budded off nonadherent hematopoietic cells (EHT). SCH79797 or Y-27632 treatment did not affect flk1 + cell percentage in day 4 EBs (Figures S2C-S2H) but significantly accelerated EHT 48 hr after seeding in BL-CFC medium, destabilizing the tight junctions of hemogenic endothelial cells ( Figure 3E ). These results were also confirmed by F2r knockdown experiments ( Figure 3E ). To verify the causal relationship between tight junction dissolution and EHT, we knocked down ZO-1 using siRNA ( Figure S2I ) and found that CD41 + cell percentage and the expression of hematopoietic marker genes were significantly increased ( Figures 3F and 3G )
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F2r Regulates Hematopoiesis and EHT (G) qPCR analyses of hematopoietic marker genes affected by ZO-1 knockdown in day 6 whole EBs. Data shown are the mean ± SEM of at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 versus the corresponding control. See also Figure S2 .
F2r Regulates Hematopoiesis and EHT without affecting flk1 + cell percentage ( Figures S2J and S2K ), suggesting that tight junction dissolution is a prerequisite of EHT. Interestingly, RhoA was previously shown to negatively regulate TGF-b induced EMT by stabilizing tight junctions between epithelial cells (Kong et al., 2008; Ozdamar et al., 2005) . Thus, these results implicated RhoA/ROCK pathway as a conserved negative regulator of both EMT and EHT by modulating tight junctions.
F2r-RhoA/ROCK Pathway Regulates EHT In Vivo Next, we used both pharmacological and genetic approaches to explore the function of F2r signaling during zebrafish hematopoiesis. The effects of SCH79797 treatment or F2r morpholino (F2r MO1) injection were dose dependent, and we found that 300 nM SCH79797 treatment or 4 ng F2r MO1 injection did not significantly affect zebrafish development (data not shown). WISH analyses showed that F2r inhibition had minimal effects on ICM markers gata1 ( Figures S3A-S3D ) and scl ( Figures  S3E-S3H ) at 24 hpf but significantly increased the expression of HSC markers cmyb and runx1 (cmyb/runx1) in the AGM region at 36 hpf ( Figure S3J , n = 62/94; Figure S3L , n = 43/59), which was confirmed by qPCR analyses (Figures S3Q and S3R) . The vasculature was not disrupted by F2r inhibition, as evident from Tg(flk1:EGFP) embryo imaging at 36 hpf ( Figures S3M-S3P) .
Injection of another translational blocking morpholino (F2r MO2), which binds to the 25 nucleotides upstream of ATG and thus cannot block F2r mRNA overexpression, confirmed the WISH results of F2r MO1 ( Figure 4A ; data not shown). Importantly, F2r mRNA overexpression repressed cmyb/runx1 expression and rescued the F2r MO2 effects ( Figure 4B ). In contrast, the expression of myeloid marker mpx in the CHT region ( Figures  S4A-S4E ) and the lymphoid marker rag1 in the thymus was not significantly changed after F2r inhibition ( Figures S4F-S4J ), and we found no expansion of gata1 + lmo2 + erythromyeloid progenitors (EMPs) in the posterior blood island (PBI) at 30 hpf ( Figures S4K-S4Q , n = 5) (Bertrand et al., 2007 (Bertrand et al., , 2010b . Consistent with the in vitro mESC hematopoietic differentiation model, Y-27632 treatment, or injection of the dominantnegative form of RhoA, RhoA-DN (T19N), promoted cmyb/ runx1 expression (data not shown). Moreover, epistatic analyses showed that RhoA/ROCK pathway mediates the downstream signaling of F2r ( Figures 4C and 4D ). Given that F2r-RhoA/ ROCK pathway negatively regulates transition from hemogenic endothelial cells to hematopoietic cells in vitro, we hypothesize that it may function similarly during HSC induction in vivo, which also involves EHT (Bertrand et al., 2010a; Boisset et al., 2010; Kissa and Herbomel, 2010) . To test this hypothesis, we generated Tg(cmyb:EGFP; flk1:mCherry) double-transgenic zebrafish embryos to document in vivo EHT events ( Figure 4E ). Consistent with previous findings (Bertrand et al., 2010a) Figures 4F-4H , n = 7; Movie S1), whereas SCH79797 ( Figures  4I-4K , n = 5; Movie S1) or Y-27632 ( Figures 4L-4N , n = 7; Movie S1) treatment significantly increased this number to 0.32 and 0.37 cells per somite per hour, respectively ( Figure 4X ). Consistently, the EHT frequency was 0.23 per somite per hour in the control MO injection group ( Figures 4O-4Q , n = 4; Movie S2), whereas F2r MO1 ( Figures 4R-4T , n = 6; Movie S2) or F2r MO2 ( Figures 4U-4W , n = 5; Movie S2) injection increased this number to 0.35 and 0.34 cells per somite per hour, respectively ( Figure 4Y ). Taken together, these data demonstrated that F2r-RhoA/ROCK pathway negatively regulates EHT and HSC induction in zebrafish.
DISCUSSION
F2r plays fundamental roles in coagulation, inflammation, and carcinogenesis; however, its regulatory functions during embryonic development remain unclear (Coughlin, 2005) . Here, using mESCs and zebrafish as model systems, we demonstrated that F2r signaling functions as an evolutionarily conserved pathway regulating embryonic hematopoiesis and EHT. Interestingly, inhibition of F2r signaling promotes transition from endothelial to hematopoietic cells, whereas F2r receptor knockout leads to vasculature damage and severe bleeding (Griffin et al., 2001 ). Thus, F2r signaling seems to act as an important molecular switch, keeping the balance between hematopoietic and vascular development. The effect of F2r inhibition on adult hematopoiesis in the kidney marrow was also tested, but we were unable to detect significant changes (data not shown), suggesting that F2r inhibition probably does not increase the number of endothelial cells that are specified to HSC fate but, rather, increases the rate of HSC induction through accelerating EHT. Previous studies showed that endothelial-specific depletion of G 13 generated a phenotype that is nearly identical to F2r knockout mice (Ruppel et al., 2005) , suggesting that G 13 -coupled mechanisms may account for the function of F2r during early development. Consistently, our findings demonstrated that RhoA/ROCK pathway, which is activated by G 13 , mediates F2r signaling during hematopoiesis, emphasizing the importance of F2r-G 13 -RhoA/ROCK axis during vertebrate embryogenesis. The PAR family also includes PAR2, PAR3, and PAR4 (Coughlin, 2000) . In contrast to F2r (PAR1), PAR2 is constitutively downregulated during hematopoietic development, whereas PAR3 and PAR4 show no significant expression changes (data not shown), implicating that the distinctive expression pattern of F2r determines its important functions during hematopoietic development. It is tempting to speculate that other G 13 -coupled GPCRs may have similar functions in fine-tuning the developmental processes, possibly with the same mechanisms.
EHT is a fundamental process for hematopoietic stem and progenitor cell induction. Likewise, EMT also plays pivotal roles during different stages of gastrulation (Thiery et al., 2009) , and ectopic induction of EMT in mammary epithelial cells generates mammary stem cell-like cells (Mani et al., 2008) . In this study, we provided evidence that RhoA/ROCK pathway, a known regulator of EMT, also modulates EHT, linking the two different cell transitions with a conserved mechanism. Up until now, the only reported EHT regulator is Runx1, which is a key transcription factor responsible for initiation of EHT but is dispensable thereafter (Chen et al., 2009 ). Our findings highlight the notion that EHT is also tightly regulated by environmental factors. Given that RhoA/ROCK pathway responds to multiple extracellular signals (Etienne-Manneville and Hall, 2002) , it is very likely that modulation of other upstream receptors may also affect EHT. Importantly, recent studies showed that Oct4 is sufficient to transform skin fibroblasts into hematopoietic cells, although at a relatively low efficiency (Szabo et al., 2010) . Inhibition of F2r-RhoA/ROCK pathway appears to be an effective strategy to promote induction of hematopoietic stem and progenitor cells, enabling the potential treatment of hematopoietic diseases, such as Fanconi anemia or leukemia.
EXPERIMENTAL PROCEDURES Microarray Data Analyses
All statistical computations were performed by R (http://www.r-project.org), and in-house scripts are available upon request. Raw microarray data set Multilayer confocal scanning was performed from 32 to 48 hpf, followed by z stack processing. DA, dorsal aorta; AV, axial vein. Arrowheads indicate cells that are undergoing EHT. Note that dorsal neurons are nonspecifically labeled in these embryos, whereas the cmyb + cells under the AV were hematopoietic precursors.
(X and Y) Statistical analyses of EHT frequency. Data shown are the mean ± SEM of at least three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001 versus the corresponding control. See also Figures  S3 and S4 and Movies S1 and S2.
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F2r Regulates Hematopoiesis and EHT was downloaded from NCBI's Gene Expression Omnibus repository with accession numbers GSE2972 and GSE3749 (Edgar et al., 2002) . Standard Affymetrix quality assessment procedures were performed with BioConductor packages simpleaffy (Wilson and Miller, 2005) and AffyPLM (Bolstad et al., 2003) . Expression values among arrays were further normalized and estimated using the RMA algorithm . To identify differentially expressed genes (DEGs) during the differentiating process, a moderated linear model was employed with time point 0 hr as the ''baseline'' (Smyth, 2004) . Raw p values derived from empirical Bayes testing were further corrected by the BH95 procedure for multiple hypothesis testing (Benjamini and Hochberg, 1995) . Only genes with corrected p values less than 0.05 and fold changes larger than 1.5 were identified as DEGs. The putative mouse GPCR list was retrieved from GPCRDB (Horn et al., 1998) , and the diverged sequence identities were mapped to NCBI RefSeq identities by sequence comparison using NCBI BLAST. Differentially expressed GPCRs were further identified by intersecting with the aforementioned DEG list.
Hematopoietic Differentiation of mESCs
All mESC culture and hematopoietic differentiation procedures followed standard protocol (McKinney-Freeman et al., 2008) . Briefly, undifferentiated mESCs were cultured in DMEM, and changed to IMDM 2 days before hematopoietic differentiation. To form hematopoietic EBs, mESCs were dissociated into single cells using trypsin, diluted at 100 mESCs/15 ml differentiation medium (200 mg/ml holo-transferrin, 4.5 mM monothioglycerol, 15% differentiation serum, 50 mg/ml ascorbic acid in IMDM), and cultured in an inverted manner. EBs were pooled into 35 mm Petri dish at day 2, and cultured with rotation for another 4 days. Fresh differentiation medium was changed every 2 days. Stable mESC lines were constructed by lentivirus transfection and flow cytometry sorting based on GFP expression. Methylcellulose-based colony-forming cell assay was performed according to the manufacturer's instructions (M3434; STEMCELL Technologies). BL-CFC assay was performed as previously described (Kennedy et al., 1997) .
Real-Time qPCR
Total RNAs were extracted from whole EBs or 20 embryos using TRIzol reagent (Sigma-Aldrich). RNA was reverse transcribed using random hexamers and M-MLV Reverse Transcriptase (Promega). A 23 PCR Mix (Tiangen) and Eva Green (Biotium) were used for the real-time qPCR analysis, with an MX3000P Stratagene PCR machine. The relative expression values were normalized against the internal control gapdh. Primer sequences are listed in Supplemental Experimental Procedures.
Flow Cytometry
Cells were resuspended in PBS containing 1% (wt/vol) BSA (Sigma-Aldrich). For surface staining of CD41 and flk1, cells were incubated on ice for 30 min with fluorochrome-conjugated antibodies at 1:50 dilution ratio. Stained cells were washed twice and analyzed with FACSAria (BD Biosciences). Results were processed using FlowJo software.
Zebrafish Maintenance and Embryo Production
Zebrafish maintenance, breeding, and staging were performed as described previously (Kimmel et al., 1995) .
Morpholinos and siRNAs
Morpholino antisense oligonucleotides (MOs) were obtained from Gene Tools. siRNAs were designed and synthesized by GenePharma. The sequence information for MO and siRNA is listed in Supplemental Experimental Procedures.
In Vitro RNA Synthesis and WISH Antisense riboprobes were synthesized using the DIG RNA Labeling kit (Roche) according to the manufacturer's instructions. mRNAs were synthesized using mMessage mMachine kit (Ambion). WISH was performed as previously described (Kissa et al., 2008) .
Fluorescence Microscopy
Leica SP5 inverted confocal microscope (Leica) was used for all confocal experiments. Four-dimensional time-lapse imaging was performed as previously described with modifications (Bertrand et al., 2010a) . z stacks were taken every 10 min from 32 to 48 hpf. Movies were created after processing with LAS AF software (Leica). Tg(flk1:EGFP) images were acquired by Olympus SZX16 system.
Statistical Analysis
Quantitative data were expressed as mean ± SEM of at least three independent experiments. Statistical significance was determined by two-tailed Student's t test, or by one-way analysis of variance (ANOVA) followed by LSD post hoc test for multiple comparisons. A p value less than 0.05 was considered statistically significant.
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